MedImmune LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1987-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://medimmune.com
A Study to Evaluate the Immunogenicity of Quadrivalent Live Attenuated Influenza Vaccine (LAIV) in Children
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-03-23
- Last Posted Date
- 2011-09-26
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 2312
- Registration Number
- NCT01091246
- Locations
- 🇺🇸
Research Site, Franklin, Wisconsin, United States
A Study to Evaluate the Efficacy and Safety of CAM-3001 (Drug) in Subjects With Rheumatoid Arthritis
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-01-18
- Last Posted Date
- 2018-06-25
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 516
- Registration Number
- NCT01050998
- Locations
- 🇺🇦
Research Site, Kyiv, Ukraine
Safety Study of CAT-8015 to Treat Advanced B-cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia (NHL or CLL)
- First Posted Date
- 2009-12-11
- Last Posted Date
- 2018-04-09
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 23
- Registration Number
- NCT01030536
- Locations
- 🇵🇱
Research Site, Łódź, Poland
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
Completed
- Conditions
- First Posted Date
- 2009-09-24
- Last Posted Date
- 2012-11-14
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 3000
- Registration Number
- NCT00983606
- Locations
- 🇺🇸
Research Site, Monroe, Wisconsin, United States
A Clinical Study Using MEDI-551 in Adult Participants With Relapsed or Refractory Advanced B-Cell Malignancies
- First Posted Date
- 2009-09-24
- Last Posted Date
- 2020-05-13
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 136
- Registration Number
- NCT00983619
- Locations
- 🇪🇸
Research Site, Madrid, Spain
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Participants With Systemic Lupus Erythematosus or Myositis
- First Posted Date
- 2009-09-18
- Last Posted Date
- 2016-10-27
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 118
- Registration Number
- NCT00979654
- Locations
- 🇨🇱
Research Site, Santiago, Chile
A Study to Assess Pharmacokinetics, Safety and Tolerability of Multiple Doses of CAT-354 in Subjects With Moderate Asthma
Phase 1
Terminated
- Conditions
- Interventions
- First Posted Date
- 2009-09-10
- Last Posted Date
- 2017-05-02
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 23
- Registration Number
- NCT00974675
- Locations
- 🇬🇧
Chiltern International Limited, Slough, Berkshire, United Kingdom
A Study to Evaluate the Effectiveness and Safety of MEDI-528 in Adults
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-08-31
- Last Posted Date
- 2014-06-04
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 329
- Registration Number
- NCT00968669
- Locations
- 🇨🇳
Research Site, Taoyuan, Taiwan
A Study to Evaluate the Immunogenicity of Quadrivalent LAIV (MEDI8662) in Adults 18 to 49 Years of Age
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-08-06
- Last Posted Date
- 2018-05-03
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 1800
- Registration Number
- NCT00952705
- Locations
- 🇺🇸
Coastal Clinical Research, Inc., Mobile, Alabama, United States
🇺🇸Miami Research Associates, Miami, Florida, United States
🇺🇸Benchmark Research, Metairie, Louisiana, United States
A Study of the Safety and Tolerability of MEDI-551 in Scleroderma
- First Posted Date
- 2009-07-27
- Last Posted Date
- 2014-11-13
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 50
- Registration Number
- NCT00946699
- Locations
- 🇬🇧
Research Site, London, United Kingdom
© Copyright 2024. All Rights Reserved by MedPath